ValueAct Capital (Mason Morfit)'s MDLN Position Overview
ValueAct Capital (Mason Morfit) (via Valueact Holdings, L.P.) currently holds 4.15 M shares of Medline Inc. (MDLN) worth $144.16 M, representing 2.33% of the portfolio. First purchased in 2026-Q3, this recently established position has been held for 1 quarters.
Based on recent 13F filings, ValueAct Capital (Mason Morfit) has initiated a new position in MDLN, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
ValueAct Capital (Mason Morfit)'s Medline (MDLN) Holding Value Over Time
Track share changes against reported price movement
Quarterly Medline (MDLN) Trades by ValueAct Capital (Mason Morfit)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2026 | +4.15 M | New Buy | 4.15 M | $34.70 |
ValueAct Capital (Mason Morfit)'s Medline Investment FAQs
ValueAct Capital (Mason Morfit) first purchased Medline Inc. (MDLN) in Q3 2026, acquiring 4,154,600 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
ValueAct Capital (Mason Morfit) has held Medline Inc. (MDLN) for 1 quarters since Q3 2026.
ValueAct Capital (Mason Morfit)'s largest addition to Medline Inc. (MDLN) was in Q3 2026, adding 4,154,600 shares worth $144.16 M.
According to the latest 13F filing for Q3 2026, ValueAct Capital (Mason Morfit)'s firm, Valueact Holdings, L.P., owns 4,154,600 shares of Medline Inc. (MDLN), valued at approximately $144.16 M.
As of the Q3 2026 filing, Medline Inc. (MDLN) represents approximately 2.33% of ValueAct Capital (Mason Morfit)'s publicly disclosed stock portfolio, making it one of their key holdings.
ValueAct Capital (Mason Morfit)'s peak holding in Medline Inc. (MDLN) was 4,154,600 shares, as reported at the end of Q3 2026.